Revolutionary and innovative product-kit approach makes your test process reliable, easy-to-use and convenient. Use your own 3D-based culture HTS assays for novel cancer treatment for higher biological relevance through enriched CSC culture.
Your reliable partner to help save time and resources in early drug discovery for novel cancer treatment: Conducting enriched CSC 3D-based culture assays for primary HTS to secondary validation, hit to lead assessment, lead optimization validation, fresh human tumor validation to in vivo efficacy studies.
Stemtek Therapeutics specializes in Cancer Stem Cell centric approaches to developing novel cancer treatments to put an end to relapse and metastasis. At StemTek Therapeutics we believe that the cancer stem cell compartment of a tumor must be targeted to achieve a long-term and permanent response to cancer treatment.
Barcelona, Spain | October 19, 2016
Bilbao, Spain | April 12, 2016
Vuelta de Obligado, Argentina | January 20, 2016